Nautilus Biotechnology, Inc. NAUT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -8.07% | 1.55% | -6.65% | -1.52% | 9.71% |
| Total Depreciation and Amortization | 1.56% | -13.01% | -7.05% | -1.91% | -0.86% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.14% | -9.58% | -3.22% | 12.35% | -6.30% |
| Change in Net Operating Assets | 84.75% | -45.87% | 22.78% | -464.68% | 77.95% |
| Cash from Operations | 3.24% | -4.78% | -5.86% | -12.15% | 17.35% |
| Capital Expenditure | -218.28% | 10.98% | -109.02% | 41.63% | -5.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.75% | -15.38% | 1,329.97% | 18.51% | -94.15% |
| Cash from Investing | -13.18% | -15.53% | 1,708.51% | 74.12% | -96.88% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -89.34% | -77.92% | 994.06% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -89.34% | -77.92% | 994.06% | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -92.95% | -165.24% | 119.48% | -8.55% | -968.09% |